成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 6530-09-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 6530-09-2
Chemical Structure| 6530-09-2
Structure of 6530-09-2 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 6530-09-2 ]

Related Doc. of [ 6530-09-2 ]

Alternatived Products of [ 6530-09-2 ]
Product Citations

Product Details of [ 6530-09-2 ]

CAS No. :6530-09-2 MDL No. :MFCD00137395
Formula : C7H16Cl2N2 Boiling Point : -
Linear Structure Formula :C7H12N(NH2)·2HCl InChI Key :STZHBULOYDCZET-UHFFFAOYSA-N
M.W : 199.12 Pubchem ID :197853
Synonyms :

Calculated chemistry of [ 6530-09-2 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 54.98
TPSA : 29.26 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.44 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 1.51
Log Po/w (WLOGP) : 1.26
Log Po/w (MLOGP) : 1.22
Log Po/w (SILICOS-IT) : 0.38
Consensus Log Po/w : 0.87

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.03
Solubility : 1.88 mg/ml ; 0.00942 mol/l
Class : Soluble
Log S (Ali) : -1.73
Solubility : 3.69 mg/ml ; 0.0185 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.29
Solubility : 101.0 mg/ml ; 0.508 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.93

Safety of [ 6530-09-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6530-09-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 6530-09-2 ]

[ 6530-09-2 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 704-91-6 ]
  • [ 6530-09-2 ]
  • [ 110-17-8 ]
  • N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-1H-indazole-6-carboxamide fumarate [ No CAS ]
  • 2
  • [ 478148-62-8 ]
  • [ 6530-09-2 ]
  • [ 478149-53-0 ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; HATU; In DMF (N,N-dimethyl-formamide); at 0 - 20℃; for 2.5h; Acid C9 (1.96 g, 12.0 MMOL), DIEA (6.27 mL, 36.0 mmol), and R- (+)-3- aminoquinuclidine dihydrochloride (2. 42 g, 12.1 mmol) are added to DMF (60 mL), and the reaction is cooled in an ice bath. HATU (4.57 g, 12.0 mmol) is added, the solution allowed to warm to rt over 2.5 h, then CONCENTRATED IN VACUO. The residue is stirred with saturated NAHCO3 (30 mL) for 30 min, then extracted with CHC13 (10 X 50 mL). The combined organic layer is dried (NA2S04) and is concentrated in vacuo. The crude material is chromatographed over 130 g slurry-packed silica gel, eluting with 0.5% ammonium hydroxide in 10% MEOH/CHC13. The appropriate fractions are combined and concentrated to a residue.
  • 3
  • [ 6624-49-3 ]
  • [ 6530-09-2 ]
  • isoquinoline-3-carboxylic acid {(S)-1-azabicyclo[2.2.2]oct-2-yl}-amide monohydrochloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
529 mg of <strong>[6624-49-3]isoquinoline-3-carboxylic acid</strong> hydrate are dissolved in 18 mi of DMF, followed by addition of 508 mg of 1-hydroxy-benzotriazol and 1.81 G of dicyclohexyl-carbodiimide. After stirring for 1 h at r. t. , the precipitated dicylohexyl-urea is filtered off and 500 mg of 3 (S)- aminoquinuclidine dihydrochloride and 1.3 ml of ethyl-diisopropylamine is added to the filtrate. After stirring for 48 h at room temperature, a second portion of dicylohexyl-urea is filtered off and washed with MeOtBu/DMF (4: 1). Wash solution and filtrate are combined and crystallized by standing over night at 5° The crystalline precipitate is filtered off and washed with MeOtBu/DMF (4: 1), followed by MeOtBu to yield the title compound as monohydrochloride. NMR (1H, 400 MHz, AH d6-DMSO) : 1.75 (1H, t), 1.96 (2H, m), 2.12 (1H, q), 2.24 (1H, d), 3.24 (3H, m), 3.43 (2H, m), 3.65 (1'H, t), 4.49 (1H, q), 7. 86 (1H, t), 7.92 (1H, t), 8. 24 (1H, d), 8.30 (1H, d), 8. 61 (1H, s), 9.31 (1 H, d), 9. 46 (1H, s), 10.59 1H, br). MS (ES+) : 282 (MH)+
  • 4
  • [ 77837-08-2 ]
  • [ 6530-09-2 ]
  • [ 1392219-90-7 ]
YieldReaction ConditionsOperation in experiment
70% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In acetonitrile; at 20℃; for 24h; General procedure: Method 3: [0050] After 300 mg (1.39 mmol) of <strong>[77837-08-2]6-oxo-1-phenyl-1,6-dihydro-3-pyridinecarboxylic acid</strong> was dissolved in 10 mL of acetonitrile, 415 mg (2.08 mmol) of 3-aminoquinuclidine dihydrochloride and 718 mg (5.56 mmol) of diethylisopropylamide were added to the solution. Afterward, 207 mg (1.53 mmol) of 1-hydroxylbenzotriazole (HOBt) and 266 mg (1.39 mmol) of N-(3-dimethylaminopropyl)-N?-ethylcarbodiimide hydrochloride (EDC) were added to the reaction solution. This reaction solution was stirred at room temperature for about 24 hours. After termination of the reaction was determined by liquid chromatography, the solvent was removed in vacuo and then extracted three times with chloroform and an aqueous NaOH solution (pH=12), followed by purification using liquid chromatography (chloroform:methanol: ammonia water=10:1:0.1) to obtain a target compound (Actual yield: 317 mg, Percent yield: 70percent). [0051] 1H-NMR (CDCl3,200 MHz) delta8.11 (s, 1H), 7.75 (d, 1H), 7.40 (m, 4H), 6.65 (d, 1H), 6.26 (br, 1H), 4.15 (m, 1H), 3.39 (m, 1H), 2.89 (m, 4H), 2.53 (m, 1H), 2.06 (m, 1H), 1.53 (m, 4H)
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 6530-09-2 ]

Amines

Chemical Structure| 119904-90-4

[ 119904-90-4 ]

(S)-Quinuclidin-3-amine dihydrochloride

Similarity: 1.00

Chemical Structure| 123536-14-1

[ 123536-14-1 ]

(R)-3-Aminoquinuclidine dihydrochloride

Similarity: 1.00

Chemical Structure| 1157849-51-8

[ 1157849-51-8 ]

(S)-1-Methylpiperidin-3-amine dihydrochloride

Similarity: 0.88

Chemical Structure| 1440799-70-1

[ 1440799-70-1 ]

(1-Methylpiperidin-2-yl)methanamine dihydrochloride

Similarity: 0.85

Chemical Structure| 902152-76-5

[ 902152-76-5 ]

(S)-1-Methylpiperidin-3-amine

Similarity: 0.85

Related Parent Nucleus of
[ 6530-09-2 ]

Aliphatic Heterocycles

Chemical Structure| 119904-90-4

[ 119904-90-4 ]

(S)-Quinuclidin-3-amine dihydrochloride

Similarity: 1.00

Chemical Structure| 123536-14-1

[ 123536-14-1 ]

(R)-3-Aminoquinuclidine dihydrochloride

Similarity: 1.00

Chemical Structure| 1157849-51-8

[ 1157849-51-8 ]

(S)-1-Methylpiperidin-3-amine dihydrochloride

Similarity: 0.88

Chemical Structure| 1440799-70-1

[ 1440799-70-1 ]

(1-Methylpiperidin-2-yl)methanamine dihydrochloride

Similarity: 0.85

Chemical Structure| 1001353-92-9

[ 1001353-92-9 ]

(R)-1-Methylpiperidin-3-amine

Similarity: 0.85

Quinuclidines

Chemical Structure| 119904-90-4

[ 119904-90-4 ]

(S)-Quinuclidin-3-amine dihydrochloride

Similarity: 1.00

Chemical Structure| 123536-14-1

[ 123536-14-1 ]

(R)-3-Aminoquinuclidine dihydrochloride

Similarity: 1.00

Chemical Structure| 67496-77-9

[ 67496-77-9 ]

Quinuclidin-4-ylmethanamine dihydrochloride

Similarity: 0.81

Chemical Structure| 18339-49-6

[ 18339-49-6 ]

1-Azabicyclo[2.2.2]octan-4-amine dihydrochloride

Similarity: 0.79

Chemical Structure| 26458-78-6

[ 26458-78-6 ]

Quinuclidine-4-carbonitrile

Similarity: 0.61

; ;